Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Study documents wrong-site, wrong-patient procedure errors

October 17, 2010 10:30 pm | by EurekAlert | News | Comments

(JAMA and Archives Journals) Data from one liability insurance database in Colorado indicate that wrong-site and wrong-patient surgical and procedure errors continued to occur despite nationwide steps to help prevent them, according to a report in the October issue of Archives of Surgery,...

TOPICS:

Vaccine Leaders All Over the World Talking About China Vaccine Opportunities at VacChina 2010 -- the No.1 China Focused Vaccine Partnering Forum

October 17, 2010 8:33 pm | by Bio-Medicine.Org | News | Comments

SHANGHAI, Oct. 17 /PRNewswire-Asia/ -- At the end of 2009, the vaccine industry raised so much concern worldwide that the headlines of the business media were occupied by various kinds of news about vaccine enterprises. For example, Sinovac Biotech Co., Ltd. successfully landed on the...

TOPICS:

Experimental Drug Preserves Memory in Rodents

October 17, 2010 8:32 pm | by Massachusetts Institute of Technology | News | Comments

A new compound prevents age-related memory loss by blocking part of the stress system.

TOPICS:
Advertisement

Tocotrienols Shown to be Effective in Lowering Fat Levels in Blood

October 17, 2010 7:32 pm | by Bio-Medicine.Org | News | Comments

Tocotrienols Shown to be Effective in Lowering Fat Levels in Blood -- SINGAPORE, Oct. 17 /PRNewswire-Asia/ --

TOPICS:

Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010

October 17, 2010 12:32 pm | by Bio-Medicine.Org | News | Comments

SAN CARLOS, Calif., Oct. 17 /- Nektar Therapeutics (Nasdaq: NKTR ) today presented new preclinical data demonstrating that NKTR-181, a mu-opioid analgesic with a novel molecular structure, dramatically reduces abuse liability while providing analgesia comparable to oxycodone and morphine....

TOPICS:

Blood pressure, glaucoma links in migraine patients; eye care goes digital and mobile

October 17, 2010 6:31 am | by EurekAlert | News | Comments

(American Academy of Ophthalmology) Data on glaucoma risk in people with migraine and on innovative uses of mobile, digital technology are featured in today's scientific program, to be presented at the 2010 American Academy of Ophthalmology -- Middle East-Africa Council of Ophthalmology...

TOPICS:

Galenea wins $4.5M NIH grant

October 17, 2010 4:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cambridge biopharmaceutical firm Galenea Corp. has won a $4.5 million grant from the National Institute of Mental Health for a technology platform aimed at identifying compounds to treat schizophrenia.

TOPICS:

Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date

October 17, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

WORCESTER, Mass., Oct. 15 /- Generex Biotechnology Corporation (Nasdaq: GNBT, www.generex.com ) today announced that it reconvened a special meeting of stockholders (the "Special Meeting") on October 15, 2010 at 10:00 a.m. (local time) at the Meeting Rooms, Westin Harbour Castle Hotel, 1...

TOPICS:
Advertisement

New Online Pharmacy RxBuys.com is Launched by One of the Leading Pharmaceutical Companies, Rx Corp

October 17, 2010 3:31 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn., Oct. 17 /- The new online pharmacy was launched after the company had studied the market of pharmaceuticals, coming to the conclusion there are not enough reliable and trustworthy places to shop for high quality prescription medications. With the many years of experience...

TOPICS:

Long-Term Data Show Novartis Once-Yearly Reclast Preserves Bone Mass and Provides Fracture Protection in Postmenopausal Osteoporosis

October 16, 2010 4:31 pm | by Bio-Medicine.Org | News | Comments

EAST HANOVER, N.J., Oct. 16 /- Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast® (zoledronic acid) injection in postmenopausal women with osteoporosis.(1) The study of more than 1,200 women was presented this...

TOPICS:

ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™

October 16, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Oct. 16 /- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY™ (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye...

TOPICS:

Medical Device Conference Opens October 18, 2010 With Free Executive Workshops; Full Conference Highlights Latest Industry Trends, Technology Innovations and Keynote Speeches ...

October 16, 2010 10:31 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Oct. 16 /PRNewswire-USNewswire/ -- AdvaMed 2010 : The MedTech Conference opens on Monday, October 18 with a series of free educational Executive Workshops focused on bringing products to the US markets, a 1/2 day entrepreneur bootcamp, and minimizing risk and global...

TOPICS:

Acute Cardiac Care 2010

October 16, 2010 12:31 am | by EurekAlert | News | Comments

(European Society of Cardiology) Today in most countries of the world almost 50 percent of patients in hospital for a cardiac condition began their treatment as emergency cases: chest pain at home or cardiac arrest in the street.

TOPICS:

Excelsior Medical 5 ml Fill in 6 cc Prefilled Saline Flush Syringes: Recall - Potential Loss of Sterility

October 15, 2010 12:31 pm | by U.S. Food & Drug Administration | News | Comments

Exposure to syringes with a sterility issue could result in systemic infection, which may lead to serious injury and/or death.

TOPICS:

Sun Healthcare spinoff to offer $225M in notes

October 15, 2010 11:45 am | by The Associated Press | News | Comments

Health care facility operator Sun Healthcare Group Inc. said Friday that its spinoff company Sabra Health Care REIT Inc. plans to offer $225 million in senior notes due 2018 in a private offering.Sun Healthcare is separating into two separate companies. Sabra Health Care will own all of the...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading